Cvs Health (CVS) Common Equity (2009 - 2026)

Cvs Health has reported Common Equity for 18 years, with the latest figure at $77.5 billion in Q1 2026.

• For the quarter ending Q1 2026, Common Equity changed 0.45% year-over-year to $77.5 billion; the trailing twelve-month figure through Mar 2026 stood at $77.5 billion (changed 0.45% YoY), and the FY2025 full-year result was $75.4 billion, changed 0.46% from the prior year.
• Common Equity for Q1 2026 stood at $77.5 billion, up from $75.4 billion in the prior quarter.
• The five-year high for Common Equity was $77.6 billion in Q2 2025, with the low at $71.5 billion in Q3 2022.
• Historically, Common Equity has averaged $74.7 billion across 5 years, with a median of $75.1 billion in 2024.
• Annual changes were most pronounced in 2022 — Common Equity declined 4.2% — and 2023, when it rose 6.78%.
• Cvs Health's Common Equity stood at $71.8 billion in 2022, then advanced by 6.78% to $76.6 billion in 2023, then retreated by 1.18% to $75.7 billion in 2024, then decreased by 0.46% to $75.4 billion in 2025, then grew by 2.75% to $77.5 billion in 2026.
• The last three Common Equity figures came in at $77.5 billion (Q1 2026), $75.4 billion (Q4 2025), and $73.1 billion (Q3 2025), per Business Quant data.